Low/Intermediate PCa Video Chat, June 9, 2025

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:

Men (Only) Speaking Freely…1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/
Veterans Healthcare Navigation… 1st & 3rd Tuesdays @ 8.00 pm Eastern https://ancan.org/veterans/

AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.

AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.

AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download

AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.

All AnCan’s groups are free and drop-in … join us in person sometime!

You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/
Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Editor’s Pick: Being younger doesn’t mean a prostatectomy is your best treatment option. (bj)

Topics Discussed
Intraductal Carcinoma of the Prostate (IDC-P) needs treatment and you shouldn’t delay; the traditional approach to IDC-P is surgery and it is unclear how well new treatment options will work; with IDC-P consider germline (e.g. PROMISE) and somatic genetic testing (e.g. DECIPHER); what is the relationship between IDC-P and cribriform; get a second opinion on the biopsy; if you are 72 or older a prostatectomy is not advisable; just because you are younger doesn’t mean that surgery is your best treatment option; we have a tendency to hang onto to each PSA test, but we need to remember that the trend is our friend.

Chat Log

AnCan Barniskis – rick
How Citizen Scientists are Using AI to Guide Their Testing and Treatment Decisions w. Russ Hollyer Wed Jul 9, 2025 at Noon Eastern Navigating complex cancer care—choosing tests, interpreting results, and planning treatment. Learn how to use AI to navigate the process https://community.cancerpatientlab.org/c/events/how-citizen-scientists-are-using-ai-to-guide-their-testing-and-treatment-decisions-russ-hollyer?mc_cid=a493cef7cf&mc_eid=838454d636

AnCan Barniskis – rick
Dr. Epstein https://advanceduropathology.com/

AnCan Barniskis – rick
Dr. Zhou https://profiles.mountsinai.org/ming-zhou

Stuart
ming.zhou@mountsinai.org

AnCan Barniskis – rick
Dr. Christian Pavlovich , Johns Hopkins https://profiles.hopkinsmedicine.org/provider/christian-pavlovich/2703813

AnCan Barniskis – rick
What if You Could Predict the Risk of Radiation Effects – Prostox and Beyond https://ancan.org/event/special-presentation-what-if-you-could-predict-the-risk-of-radiation-effects-prostox-and-beyond/

AnCan Barniskis – rick
The trend is your friend

George (Chicago)
Thank you, gentlemen.

Low/Intermediate PCa Video Chat, June 9, 2025